Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already in...
Cannabis stocks soared following Tuesday's news that the DEA intends to designate marijuana from Schedule I to Schedule III.
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decisi...
The conversation around cannabis legalization in Pennsylvania is pivoting towards a potential state-run model, akin to the exis...
